We are all watching what one tiny virus can do to the entire globe. While we are restricted inside our houses, scientists are tirelessly working to find a cure for the disease. At the moment, we all know that prevention is the only cure for the disease. To achieve this feat, CEPI (Coalition for Epidemic Preparedness Innovations) from Norway has signed three funding agreements. The agreements were signed in order to find a vaccine that can protect against the coronavirus. Richard Hatchett, CEO of CEPI, urges for a coronavirus vaccine to be made even before we know it works, according to STATNews.
As of now, CEPI has developed eight vaccines, and two are yet to roll out. The vaccines are based on partnerships with GSK (GlaxoSmithKline) by using their adjuvants. One should also note the fact that other companies like Johnson & Johnson and Sanofi are already on this race to develop vaccines. Notably, they have signed agreements BARDA (Biomedical Advanced Research and Development Authority) to meet the U.S. requirements. And if they win, it can also be a global solution in fighting the pandemic. Also, on the other side, global leaders are pushing companies to find a quick exit as soon as possible. Therefore, a quicker exit will help everything return to normal.
Vaccinating against the coronavirus
When the disease emerged first, we didn’t know how it would behave in its first place. But what we have before us is billions of people waiting to get immunized against the disease. Therefore, we can multiple manufacturers rising to tackle global production on a vast scale. Also, the economic situation of the countries first needs restoration in order to procure their vaccines.
Also, we need to understand the reality behind manufacturing these vaccines. We cannot abruptly start the production by compromising the safety of people. The fact is we need to know whether the vaccine will definitely work against the disease, and this is accomplished by intense clinical trials on patients. With people like Bill Gates proposing to invest entire funds on the production of vaccines, we need to know whether the vaccine is working in the first place. What’s the point in manufacturing vaccines without even knowing its working capacity? Also, such an investment will cost us more billions than what CEPI is expecting now. With the company aiming to raise $2 billion to work in this, it is just $660 million away from it.
The global race on the roll currently, and CEPI is taking its every step to ensure that fact the vaccine is available globally and not just to a single country. This is to ensure the fact that at the end of the day, no country is becoming a loser to the pandemic, whereas one country becomes the winning side. Making it available to the most vulnerable populations and production globally will possibly help us win the race quick time.
Join our writing team and develop your writing skills, as you see your articles featured on Apple News, Google News, and all around the world. Subscribe to our newsletter, What Just Happened, where we dive deep into the hottest topics from the week!